U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
5031550315Trebananib (AMG 386) in Combination With Docetaxel for Advanced Urothelial CarcinomaWithdrawnNo Results AvailableUrothelial CarcinomaDrug: AMG 386|Drug: Docetaxelhttps://ClinicalTrials.gov/show/NCT01907308
5031650316National Cohort Study of Idiopathic and Heritable Pulmonary Arterial HypertensionRecruitingNo Results AvailablePulmonary Arterial Hypertensionhttps://ClinicalTrials.gov/show/NCT01907295
5031750317Prevention Trial of Family Focused Treatment in Youth at Risk for PsychosisCompletedNo Results AvailablePsychosisBehavioral: Family Focused Treatment|Behavioral: Enhanced Carehttps://ClinicalTrials.gov/show/NCT01907282
5031850318A Direct-to-patient Intervention to Increase Rates of Osteoporosis CareActive, not recruitingNo Results AvailableOsteoporosisBehavioral: Video-based Interventionhttps://ClinicalTrials.gov/show/NCT01907269
5031950319Comparing the Aesthetic Results of Two Common Incisions in External RhinoplastyCompletedNo Results AvailableCosmetic OutcomeProcedure: inverted V incision|Procedure: stair step incisionshttps://ClinicalTrials.gov/show/NCT01907256
5032050320The Role of Spreader Flaps in Preventing of Nasal ObstructionCompletedNo Results AvailableNasal ObstructionProcedure: spreader flaphttps://ClinicalTrials.gov/show/NCT01907243
5032150321Entecavir for Biological Agents Associated HBV Reactivation in Rheumatoid Arthritis PatientsNot yet recruitingNo Results AvailableRheumatoid Arthritis|Hepatitis B Reactivation|Exposure to Hepatitis B VirusDrug: Entecavirhttps://ClinicalTrials.gov/show/NCT01907230
5032250322Enhancing the Effectiveness of Electroconvulsive Therapy in Severe DepressionCompletedNo Results AvailableDepressionDevice: ECT Mecta 5000M|Drug: Methohexitone|Drug: Suxamethoniumhttps://ClinicalTrials.gov/show/NCT01907217
5032350323Evaluation of Inhaled Treatment in SinusitisCompletedNo Results AvailableSinusitisDrug: methylprednisolone|Drug: Budesonide|Drug: Budesonidehttps://ClinicalTrials.gov/show/NCT01907204
5032450324Ultrasound Guided Local Infiltration Analgesia for Hip ArthroscopyRecruitingNo Results AvailableHip InjuriesDrug: liposomal bupivacaine|Drug: Bupivacainehttps://ClinicalTrials.gov/show/NCT01907191
5031150311Phase I/II Single Center, Single-Treatment, Open-Label, Adaptive Clinical Trial Design Examining Pk of 2 MR Formulations of MPH in Adolescent/Pediatric With ADHDCompletedNo Results AvailableAttention-Deficit Hyperactivity DisorderDrug: HLD200 (B formulation)|Drug: HLD200 (C formulation)https://ClinicalTrials.gov/show/NCT01907360
5031250312Prognosis Value of Bioimpedance Analysis (BIA) Phase Angle at Admission in Intensive Care Unit (ICU) PatientsRecruitingNo Results AvailableIntensive Care Unit Patientshttps://ClinicalTrials.gov/show/NCT01907347
5032550325Postoperative Pain Management in Hospital and Following Discharge From Hospital.RecruitingNo Results AvailableArthropathy of Knee Jointhttps://ClinicalTrials.gov/show/NCT01907178
5031350313Dose-Response of Salmeterol in ChildrenCompletedHas ResultsAsthmaDrug: Advair Diskus100/50 µg|Drug: Flovent Diskus 100 µg|Drug: Methacholine Chloride|Drug: Albuterolhttps://ClinicalTrials.gov/show/NCT01907334
5031450314Cough and Swallow Rehab Following StrokeRecruitingNo Results AvailableIschemic StrokeBehavioral: Expiratory muscle strength training|Behavioral: Placebo expiratory training|Drug: Measures perfomed on all subjects|Behavioral: Pulmonary function test|Radiation: Fluoroscopic swallow studyhttps://ClinicalTrials.gov/show/NCT01907321
5032650326Disulfiram in Treating Patients With Glioblastoma Multiforme After Radiation Therapy With TemozolomideRecruitingNo Results AvailableGlioblastomaDrug: Temozolomide|Drug: Disulfiram|Dietary Supplement: Copper gluconatehttps://ClinicalTrials.gov/show/NCT01907165
5032750327Increase Protein Intake in ElderlyCompletedNo Results AvailableMarkedly Reduced Food IntakeOther: Protein enriched yoghurt drink and breadhttps://ClinicalTrials.gov/show/NCT01907152
5032850328Comparative Efficacy Research of Robot-Assisted Therapy With and Without Constraint-Induced Therapy in Stroke RehabilitationActive, not recruitingNo Results AvailableCerebrovascular AccidentBehavioral: Robot-assisted therapy|Behavioral: Distributed constraint-induced therapy|Behavioral: Dose-matched control therapyhttps://ClinicalTrials.gov/show/NCT01907139
5032950329HIV/STI Risk Reduction for Incarcerated Women With Interpersonal ViolenceActive, not recruitingNo Results AvailableUnsafe Sex|Physical Violence|Sexual Assault|Sexual AbuseBehavioral: Nutrition Program (NP)|Behavioral: Women's Prison CoOp (WPC)https://ClinicalTrials.gov/show/NCT01907126
5033050330Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BI 10773 in Type II Diabetes Patients With Different Degrees of Renal ImpairmentCompletedHas ResultsDiabetes Mellitus, Type 2Drug: BI 10773|Drug: BI 10773|Drug: BI 10773|Drug: BI 10773|Drug: BI 10773https://ClinicalTrials.gov/show/NCT01907113
5033150331Nintedanib (BIBF 1120) in MesotheliomaRecruitingNo Results AvailableMesotheliomaDrug: Nintedanib|Drug: Pemetrexed|Drug: Cisplatin|Drug: Cisplatin|Drug: Pemetrexed|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01907100
5033250332A Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of Intracerebroventricular BMN 190 in Patients With Late-Infantile Neuronal Ceroid Lipofuscinosis (CLN2) DiseaseActive, not recruitingNo Results AvailableJansky-Bielschowsky Disease|Batten Disease|Late-Infantile Neuronal Ceroid Lipofuscinosis Type 2|CLN2 DiseaseBiological: BMN 190https://ClinicalTrials.gov/show/NCT01907087
5033350333Quantitative Liver Function Tests Using CholatesRecruitingNo Results AvailableEnd Stage Liver Diseasehttps://ClinicalTrials.gov/show/NCT01907074
5033450334Acute Renal Failure Post Liver TransplantationActive, not recruitingNo Results AvailableAcute Renal FailureDrug: N-acetylcysteine|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01907061
5033550335Patient and Physician Knowledge of Key Safety MessagesRecruitingNo Results AvailableAnticoagulationBehavioral: Rivaroxaban (Xarelto, BAY59-7939)|Behavioral: Rivaroxaban (Xarelto, BAY59-7939)https://ClinicalTrials.gov/show/NCT01907048
5033650336Anxiety-depressive Disorder in Primary Care and Cognitive-behavioral TreatmentRecruitingNo Results AvailableAnxiety-depressive Patients Mild to ModerateBehavioral: A cognitive-behavioral intervention|Other: Usual carehttps://ClinicalTrials.gov/show/NCT01907035
5033750337Combined rTMS and Relaxation in Chronic TinnitusCompletedNo Results AvailableChronic TinnitusDevice: Left DLPFC Butterfly Coilhttps://ClinicalTrials.gov/show/NCT01907022
5033850338A PHASEII STUDY EVALUATING INTRAVENOUS MELPHALAN WITH AUTOLOGOUS WHOLE BLOOD STEM CELL TRANSPLANTATION (PBSCT)OVER THREE CYCLES IN PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER (MEL-CAP).RecruitingNo Results AvailableCastrate Resistant Prostate CancerDrug: Melphalan|Drug: Lenograstimhttps://ClinicalTrials.gov/show/NCT01907009
5033950339Proximal Row Carpectomy Versus Four Corner FusionCompletedNo Results AvailableWrist OsteoarthritisProcedure: proximal row carpectomy|Procedure: four corner fusionhttps://ClinicalTrials.gov/show/NCT01906996
5034050340Evaluation of Portal Venous System Thrombosis After Blunt Splenic Trauma Utilizing Doppler UltrasoundRecruitingNo Results AvailableThrombosis of Portal Venous System.Other: Doppler Ultrasoundhttps://ClinicalTrials.gov/show/NCT01906983

* Görseller ve İçerik tekif hakkına sahip olabilir